Doctor profile · Federal record

Dr. Monica Plazarte, DO

Endocrinology, Diabetes & Metabolism Physician (CMS: Internal Medicine) · Hudson, FL

  • NPI 1073812384
  • Accepts Medicare
  • MIPS 81.8 / 100 · 2023
  • 15 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
14100 Fivay RD, Suite 250
Hudson, FL 346677180
(727) 869-7822
fax (727) 862-0934

Credentials & registration

NPPES · NUCC
NPI registered
March 2011 — 15 yrs on file
Profile last updated
August 2, 2016
Year of graduation
2011 — 15 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
Florida #OS13509

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1073812384. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
3,648
Distinct HCPCS
9
Medicare allowed
$170,341
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 2,160 24 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 605 315 $127
82962 Blood glucose (sugar) test performed by hand-held instrument 400 192 $3
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 210 100 $35
76536 Ultrasound scan of head and neck soft tissue 90 83 $109
99215 Established patient office or other outpatient visit, 40-54 minutes 87 69 $179
96372 Injection of drug or substance under skin or into muscle 42 26 $14
99204 New patient office or other outpatient visit, 45-59 minutes 38 38 $167
10005 Fine needle aspiration biopsy using ultrasound guidance, first growth 16 15 $136

In context: peer comparison

Among 4 peers in Hudson Endocrinology, Diabetes & Metabolism Physician, average services per provider: 541. This provider delivers 6.7× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,350
Transactions
113
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Corcept Therapeutics 12 $328.65
Medtronic, INC. 5 $319.61
Novo Nordisk INC 18 $296.53
Lilly USA, LLC 18 $274.50
Beta Bionics, INC. 7 $257.90
Bayer Healthcare Pharmaceuticals INC. 6 $240.37
Amgen INC. 8 $233.91
Tandem Diabetes Care, INC. 7 $208.06
Lexicon Pharmaceuticals, INC. 4 $177.27
Sanofi-Aventis U.S. LLC 5 $171.03
Boehringer Ingelheim Pharmaceuticals, INC. 5 $160.72
Dexcom, INC. 5 $114.37
Insulet Corporation 5 $113.32
Mannkind Corporation 4 $98.55
Recordati_Rare_Diseases_INC. 4 $92.64

By nature of payment

Food and Beverage
$3,345
Education
$6

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,337
Patients
678
Total drug cost
$1,651,835
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 507 146 $10,774
Ozempic (Semaglutide) Brand 262 69 $390,704
Metformin Hcl Generic 237 79 $8,287
Trulicity (Dulaglutide) Brand 225 50 $369,590
Glipizide ER (Glipizide) Brand 154 46 $3,693
Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) Brand 111 35 $106,628
Novolog Flexpen (Insulin Aspart) Brand 100 40 $116,886
Synthroid (Levothyroxine Sodium) Brand 100 28 $11,125
Tresiba Flextouch U-100 (Insulin Degludec) Brand 100 30 $100,751
Rybelsus (Semaglutide) Brand 98 21 $150,686

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Monica Plazarte's medical specialty?
Dr. Monica Plazarte practices Endocrinology, Diabetes & Metabolism Physician in Hudson, FL.
Where does Dr. Monica Plazarte practice?
Dr. Monica Plazarte practices at 14100 Fivay RD, Hudson, FL 346677180. Office phone: 7278697822.
What is Dr. Monica Plazarte's NPI?
Dr. Monica Plazarte's National Provider Identifier (NPI) is 1073812384, issued by NPPES.
Does Dr. Monica Plazarte accept Medicare assignment?
Yes. Dr. Monica Plazarte accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Monica Plazarte commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Blood glucose (sugar) test performed by hand-held instrument (HCPCS 82962). Source: CMS Medicare Physician & Other Practitioners file.